gestational hypertension	is a	pregnancy complication
preeclampsia	is a	pregnancy complication
chronic hypertension	complicates	pregnancy
preeclampsia with severe features	requires	delivery
proteinuria	signals	preeclampsia
preeclampsia	diagnosed by	proteinuria
preeclampsia	diagnosed by	hypertension
magnesium sulfate	used for	seizure prophylaxis in preeclampsia
labetalol	used for	blood pressure control in pregnancy
nifedipine	used for	blood pressure control in pregnancy
hydralazine	used for	acute severe hypertension in pregnancy
ACE inhibitors	contraindicated in	pregnancy
ARBs	contraindicated in	pregnancy
low-dose aspirin	prevents	preeclampsia in high-risk pregnancy
obesity	increases risk for	gestational hypertension
diabetes mellitus	increases risk for	preeclampsia
chronic kidney disease	increases risk for	hypertension during pregnancy
systemic lupus erythematosus	increases risk for	preeclampsia
multiple gestation	increases risk for	preeclampsia
advanced maternal age	increases risk for	preeclampsia
placental dysfunction	underlies	preeclampsia
placental abruption	associated with	hypertensive disorders of pregnancy
HELLP syndrome	is a	variant of preeclampsia
thrombocytopenia	occurs in	HELLP syndrome
eclampsia	arises from	preeclampsia
eclampsia	causes	seizures
postpartum hypertension	occurs in	puerperium
gestational hypertension	may progress to	preeclampsia
preeclampsia with severe features	managed with	delivery
delivery	is treatment for	preeclampsia
fetal growth restriction	associated with	hypertensive disorders of pregnancy
preterm birth	associated with	hypertensive disorders of pregnancy
placental insufficiency	linked to	fetal growth restriction
magnesium sulfate	reduces risk of	seizures in preeclampsia
proteinuria	is a sign of	preeclampsia
liver dysfunction	occurs in	HELLP syndrome
elevated liver enzymes	occur in	HELLP syndrome
platelet count	decreases in	HELLP syndrome
delivery before term	occurs in	preeclampsia
cesarean delivery	more common in	preeclampsia
neonatal intensive care unit admission	associated with	hypertensive disorders of pregnancy
neonatal mortality	increased with	preeclampsia
maternal mortality	increased with	preeclampsia
uric acid	elevated in	preeclampsia
HELLP syndrome	presents with	hemolysis
HELLP syndrome	presents with	thrombocytopenia
postpartum period	requires	blood pressure monitoring
puerperium	defined as	postpartum period
delivery timing	determined by	maternal status
fetal monitoring	recommended in	hypertensive pregnancy
ultrasound	used for	fetal growth assessment in hypertensive pregnancy
Doppler velocimetry	used for	placental perfusion assessment in hypertensive pregnancy
risk assessment	performed for	hypertensive disorders of pregnancy
education	provided to	pregnant with hypertension
sodium restriction	recommended in	pregnancy with hypertension
physical activity guidance	given to	women with gestational hypertension
aspirin therapy	indicated for	high-risk hypertensive pregnancy
calcium channel blocker	is a	drug class used for
nifedipine	is a	calcium channel blocker
beta-blocker	is a	drug class used in pregnancy
labetalol	is a	beta-blocker
labetalol	used for	BP control in pregnancy
methyldopa	used for	BP control in pregnancy
delivery timing	influenced by	maternal and fetal condition
fetal growth assessment	performed by	ultrasound
placental perfusion	assessed by	Doppler velocimetry
urine protein	detected by	dipstick
proteinuria	quantified by	dipstick
maternal hemodynamics	altered in	preeclampsia
uteroplacental perfusion	reduced in	hypertensive pregnancy
angiogenic imbalance	present in	preeclampsia
endothelial dysfunction	central to	preeclampsia
risk factors	include	obesity
risk factors	include	diabetes mellitus
risk factors	include	chronic hypertension
risk factors	include	autoimmune disease
placental ischemia	contributes to	preeclampsia
hypertensive disorders	cause	fetal growth restriction
maternal hypertension	increases risk of	cesarean delivery
fetal distress	associated with	placental abruption
placental abruption	leads to	cesarean delivery
NICU admission	for neonate with	hypertensive disorder
neonatal respiratory distress	associated with	preeclampsia
preeclampsia	increases risk of	preterm birth
postpartum antihypertensive management	involves	labetalol
postpartum antihypertensive management	involves	nifedipine
postpartum antihypertensive management	involves	hydralazine
postpartum magnesium sulfate	may be continued for	seizure prophylaxis
risk stratification	guides	delivery planning
fetal wellbeing	monitored by	nonstress test
nonstress test	used for	fetal wellbeing assessment
delivery planning	guided by	maternal condition
blood pressure goal in pregnancy	defined as	<140/90 mmHg
severe hypertension threshold	defined as	â‰¥160/110 mmHg
uric acid	used as	biomarker for preeclampsia risk
platelet count	used for	HELLP screening
liver function tests	used for	HELLP screening
coagulation profile	monitored in	HELLP
platelet transfusion	required for	severe HELLP
risk of cesarean delivery	higher with	placenta previa
placenta previa	risk factor for	cesarean delivery
preeclampsia	may present with	headaches
preeclampsia	may present with	visual disturbances
preeclampsia	may present with	epigastric pain
epigastric pain	may indicate	liver involvement
epidural analgesia	considerations in	hypertensive pregnancy
labor	may be expedited by	delivery in severe preeclampsia
uterine shear	risk with	hypertensive pregnancy
placental aging	accelerated in	hypertensive pregnancy
anticoagulation	considerations in	HELLP
neonatal sepsis risk	increased with	preeclampsia
fetal growth velocity	slowed in	hypertensive pregnancy
placental calcification	more common in	hypertensive pregnancy
abnormal fetal aPLI	associated with	preeclampsia
intrauterine fetal demise	risk increased with	placental abruption
postpartum depression	risk increased with	complicated pregnancy
maternal fatigue	associated with	severe preeclampsia
antenatal corticosteroids	used for	fetal lung maturity in preterm delivery
fetal lung maturity	anticipated with	antenatal corticosteroids
preterm delivery	influenced by	maternal condition
maternal oxygenation	important in	severe preeclampsia
neonatal bilirubin	risk increased with	prematurity
neonatal hypoglycemia	risk increased with	prematurity
neonatal NICU stay	lengthened by	fetal growth restriction
mother-infant bonding	affected by	maternal hypertension
joint maternal-fetal management	essential in	hypertensive pregnancy
obstetric team	responsible for	hypertensive pregnancy care
fetal reserve	evaluated in	hypertensive pregnancy
renal function	monitored in	severe preeclampsia
hepatic function	monitored in	HELLP
platelet transfusion threshold	defined for	HELLP
postpartum hydration status	monitored in	hypertensive pregnancy
blood pressure variability	associated with	adverse outcomes in pregnancy
protein-to-creatinine ratio	used for	proteinuria assessment
urine albumin-to-creatinine ratio	used for	proteinuria assessment
neonatal morbidity	increased with	maternal preeclampsia
maternal seizures	risk in	eclampsia
fetal growth trajectory	impacted by	placental insufficiency
paternal genetics	contribute to	preeclampsia risk
lipid abnormalities	observed in	hypertensive pregnancy
diastolic pressure	target range	during pregnancy
systolic pressure	target range	during pregnancy
blood pressure med safety	considered in	pregnancy
drug teratogenicity	concerns in	antihypertensives
fetal ultrasound	frequency	ongoing in hypertensive pregnancy
neonatal jaundice	risk increased with	prematurity
maternal anemia	may accompany	hypertensive pregnancy
thyroid function	evaluated in	hypertensive pregnancy
iron supplementation	recommended in	pregnancy with hypertension
fetal cardiac monitoring	considered in	severe preeclampsia
fetal growth velocity	monitored with	serial ultrasounds
placental reserve	reduced in	hypertensive disorders
pregnancy outcome	worsened by	hypertensive disorders
delivery planning	tailored to	maternal-fetal status
antenatal care	essential for	hypertensive pregnancy
postpartum follow-up	important after	hypertensive pregnancy
long-term cardiovascular risk	increased after	preeclampsia
future pregnancy planning	impacted by	prior preeclampsia
screening for kidney disease	recommended after	preeclampsia
liver function monitoring	recommended in	HELLP
blood product availability	planned for	HELLP
neonatal infection risk	increased with	prematurity
maternal edema	common in	gestational hypertension
placental aging	accelerated in	hypertensive pregnancy
preconception counseling	advised for	women with chronic hypertension
blood pressure self-monitoring	supported in	home care
remote monitoring	feasible for	high-risk pregnancy
maternal mental health	monitored in	hypertensive pregnancy
fetal growth restriction	requires	serial ultrasounds
antepartum fetal testing	recommended for	hypertensive pregnancy
delivery by cesarean	indicated for	fetal distress with maternal instability
fetal wellbeing	preserves	birth outcome
pregnancy-induced hypertension	term used for	gestational hypertension
gestational hypertension	defined by	new-onset hypertension after 20 weeks
preeclampsia	defined by	hypertension and proteinuria or organ dysfunction
neonatal growth restriction	consequence of	placental insufficiency
antihypertensive therapy	adjusted for	gestational age
postpartum antihypertensive therapy	continued for	several days after delivery
blood pressure targets	adapted for	severe preeclampsia
HELLP	risk of	disseminated intravascular coagulation
maternal pulmonary edema	possible in	severe preeclampsia
plasma volume expansion	limited in	preeclampsia
proteinuria	persistent after	delivery
recurrence risk	elevated for	women with prior preeclampsia
anticoagulation considerations	in	HELLP
neonatal respiratory support	required for	preterm infants
intrauterine fetal demise	risk increased by	placental abruption
placenta previa	complicates	delivery planning
uterine atony	potential complication after	cesarean section
obstetric anesthesia considerations	altered in	hypertensive pregnancy
delivery logistics	complicated by	severe preeclampsia
insurance coverage	impacts	access to hypertensive pregnancy care
clinical guidelines	inform	management of hypertensive disorders of pregnancy
care coordination	essential for	hypertensive pregnancy management
patient education materials	tailored for	hypertensive pregnancy
risk communication	critical in	hypertensive pregnancy
care pathways	define	monitoring and delivery for hypertensive pregnancy
outcome prediction	aided by	maternal blood pressure trajectory
readmission risk	increased after	postpartum hypertensive disorders
mortality risk prediction	informed by	degree of proteinuria
neonatal NICU stay length	correlated with	severity of maternal hypertensive disorder
